(Q83065601)

English

Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines

scientific article published on 26 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

based on heuristic

inferred from title

author name string

A Arguedas

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

C Soley

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

C Loaiza

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

G Rincon

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

S Guevara

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A Perez

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

W Porras

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

O Alvarado

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

L Aguilar

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A Abdelnour

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

U Grunwald

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

L Bedell

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A Anemona

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

P M Dull

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

26 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

3171-3179

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasive meningococcal disease in adolescents and young adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

Serogroup Y meningococcal disease, Colombia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

W135 invasive meningococcal strains spreading in South America: significant increase in incidence rate in Argentina.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

Prevention of Pertussis Among Adolescents: Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

A search for serologic correlates of immunity to Bordetella pertussis cough illnesses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

How to make sense of pertussis immunogenicity data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

Randomized trial on the safety, tolerability, and immunogenicity of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, administered concomitantly with a combined tetanus, reduced diphtheria, and acellular pertussis va

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in a

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.045

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.02.045

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189491%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83065601&oldid=2034845691"